[go: up one dir, main page]

ES2149448T3 - Agentes terapeuticos y analiticos. - Google Patents

Agentes terapeuticos y analiticos.

Info

Publication number
ES2149448T3
ES2149448T3 ES96901878T ES96901878T ES2149448T3 ES 2149448 T3 ES2149448 T3 ES 2149448T3 ES 96901878 T ES96901878 T ES 96901878T ES 96901878 T ES96901878 T ES 96901878T ES 2149448 T3 ES2149448 T3 ES 2149448T3
Authority
ES
Spain
Prior art keywords
therapeutic
analytical agents
analytical
agents
oxoquanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901878T
Other languages
English (en)
Inventor
Sian Myra Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Application granted granted Critical
Publication of ES2149448T3 publication Critical patent/ES2149448T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A AGENTES PARA SU UTILIZACION EN UN METODO DE DETECCION DE 8 GUANOSINA, 8 ERA DE 8 8 -OXODESOXIADENOSINA, JUNTO CON METODOS PARA LA DETECCION DE BASES DE ACIDO NUCLEICO DAÑADAS.
ES96901878T 1995-05-31 1996-02-05 Agentes terapeuticos y analiticos. Expired - Lifetime ES2149448T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510954.2A GB9510954D0 (en) 1995-05-31 1995-05-31 Detection of DNA damage

Publications (1)

Publication Number Publication Date
ES2149448T3 true ES2149448T3 (es) 2000-11-01

Family

ID=10775254

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901878T Expired - Lifetime ES2149448T3 (es) 1995-05-31 1996-02-05 Agentes terapeuticos y analiticos.

Country Status (10)

Country Link
US (1) US6309825B1 (es)
EP (1) EP0828854B1 (es)
JP (1) JP3510267B2 (es)
AT (1) ATE193560T1 (es)
AU (1) AU704928B2 (es)
CA (1) CA2222513C (es)
DE (1) DE69608683T2 (es)
ES (1) ES2149448T3 (es)
GB (1) GB9510954D0 (es)
WO (1) WO1996038588A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7113696A (en) 1995-09-19 1997-04-09 Cytochem, Inc. Detection and quantitation of 8-oh-adenine using monoclonal antibodies
WO2002065889A1 (de) * 2001-02-21 2002-08-29 Rubikon Ag Verfahren zur untersuchung von zell- und gewebeproben
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008296072A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
EP2219659A4 (en) 2007-11-19 2010-11-17 Bionovo Inc METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
CA2706330A1 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
EP2334814A4 (en) * 2008-09-05 2012-04-25 Solulink Biosciences Inc METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA INJURIES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015707A1 (en) * 1991-02-27 1992-09-17 New York University Immunoassay for antibodies to oxidized dna and uses thereof

Also Published As

Publication number Publication date
EP0828854B1 (en) 2000-05-31
JPH11507435A (ja) 1999-06-29
EP0828854A1 (en) 1998-03-18
GB9510954D0 (en) 1995-07-26
DE69608683D1 (de) 2000-07-06
ATE193560T1 (de) 2000-06-15
JP3510267B2 (ja) 2004-03-22
DE69608683T2 (de) 2001-02-08
AU4627896A (en) 1996-12-18
US6309825B1 (en) 2001-10-30
CA2222513A1 (en) 1996-12-05
CA2222513C (en) 2009-10-13
AU704928B2 (en) 1999-05-06
WO1996038588A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
ES2178093T3 (es) Derivados de epotilon y su preparacion.
FI964339L (fi) Glukaanien entsyymikäsittely
ATE234092T1 (de) 2-alkylpyrrolidine
EE9800125A (et) Rotamaasse ensümaatilise aktiivsuse inhibiitorid
LV11986A (lv) Rotamazes fermenta aktivitates inhibitori
TR199600516A2 (tr) Kakaonun enzimatik muamelesi.
AU4612596A (en) Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
FI956339A0 (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminenHypotalaamisen kuukautisten puuttumisen hoitaminen
ATE203519T1 (de) Chinolinderivate als antimalariamittel
FI971802L (fi) Mycobacterium avium-kompleksilajien monistus ja ilmaisu
EP1011718A4 (en) ANTI-VIRAL TREATMENT WITH PERTUSSIS TOXIN B OLIGOMER
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
ES2149448T3 (es) Agentes terapeuticos y analiticos.
BR9602884A (pt) Subconjunto de freio de atrito e método de fabricar o mesmo
BG102064A (en) Method for increasing the retinal blood circulation
DE69611783D1 (de) Benzisoxazol- und indazol- derivate als antipsychotika
DZ1986A1 (fr) Utilisation de phénylcyclohexylcarboxamides.
BR0114884A (pt) Compostos calcilìticos
EP0710484A3 (en) Mixture of alpha-D-glucopyranosyl- (1-6) -alpha-D glucopyranose as an anti-tumor agent
NO20005548L (no) Mykobakterieinhibitorer
EP0998578A4 (en) SEL-10 AND ITS USES
TR200003084T2 (tr) Paroxetine askorbat
BR9608978A (pt) Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease
ES2186782T3 (es) Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 828854

Country of ref document: ES